Seller record · wepeptiderx.com

WePeptideRx

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The terms, the provider disclosure and the product pages say only a state-licensed compounding pharmacy. 1 more criterion also fails; see the table below.

At a glance

WePeptideRxwepeptiderx.com

6/8criteria passed
Price
Semaglutide from $149, tirzepatide from $159
Sells
compounded semaglutide with B12, compounded tirzepatide with B12, and 14 more
FDA letters
None on file

Unpaid link. WePeptideRx does not pay the site. Funding

Visit WePeptideRxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic and Mounjaro, and sermorelin, NAD+ and glutathione injections, with every price printed on one pricing page. It names no filling pharmacy.

Operating entity PureRx Biotech INC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSwepeptiderx.com/assessment, wepeptiderx.com/cart
S2Prescription gatingPASSwepeptiderx.com/cart
S3Pharmacy identificationFAILwepeptiderx.com/terms, wepeptiderx.com/provider-telehealth-disclosure
S4Compounding disclosurePASSwepeptiderx.com/pricing
S5Analytical documentationFAILwepeptiderx.com/pricing
S6Business addressPASSwepeptiderx.com/privacy, wepeptiderx.com/contact
S7Price disclosurePASSwepeptiderx.com/pricing, wepeptiderx.com/products/compounded-semaglutide
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each health assessment and alone decides eligibility, and the cart states that purchasing does not guarantee a prescription.Source: wepeptiderx.com/assessment, wepeptiderx.com/cart.
S2PASSPayment comes before the provider visit, and the cart states that provider review is required before shipping and that an order the provider does not approve is refunded in full.Source: wepeptiderx.com/cart.
S3FAILNo filling pharmacy is named. The terms, the provider disclosure and the product pages say only a state-licensed compounding pharmacy.Source: wepeptiderx.com/terms, wepeptiderx.com/provider-telehealth-disclosure.
S4PASSCompounded semaglutide is not FDA-approved, printed under each compounded price on the pricing page, and every footer states that compounded drugs are not evaluated by the FDA.Source: wepeptiderx.com/pricing.
S5FAILNo certificate of analysis or lot document is published on the product pages, the pricing page or the policies.Source: wepeptiderx.com/pricing.
S6PASSPureRx Biotech INC, doing business as WePeptideRx, at 5550 Glades Road, Suite 500 #1128, Boca Raton, FL 33431, printed in every footer and named in the privacy policy.Source: wepeptiderx.com/privacy, wepeptiderx.com/contact.
S7PASSCompounded semaglutide at $149 for a 30-day supply at the starting dose, printed against $189 and rising to $259 at the top dose, and compounded tirzepatide from $159 to $349.Source: wepeptiderx.com/pricing, wepeptiderx.com/products/compounded-semaglutide.
S8PASSNo FDA warning letter names WePeptideRx or PureRx Biotech INC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide with B12, compounded tirzepatide with B12, brand Wegovy, brand Zepbound, brand Ozempic, brand Mounjaro, compounded sermorelin, NAD+ injection, glutathione injection, B12, NAD+, glutathione and sermorelin injectable blend, compounded BPC-157 and TB-500 blend, PT-141, enclomiphene, apomorphine troche, low-dose naltrexone, methylene blue.

Unpaid link. WePeptideRx does not pay the site, and nothing is earned when it is used. Funding.

Visit WePeptideRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.